Back to Search
Start Over
Impact of AML on Patients' Lives: The Value of HM-PRO Measurements
- Source :
- Blood; November 2018, Vol. 132 Issue: 1, Number 1 Supplement 1 p5900-5900, 1p
- Publication Year :
- 2018
-
Abstract
- Background:Patient reported outcome (PRO) assessments, which include quality of life (QoL) and symptoms, have become increasingly important, aiding in identifying and informing patient needs. Patients with acute myeloid leukemia (AML) have poor clinical prognosis and outcomes. There is insufficient knowledge about the impact of disease and treatment on AML patients' lives.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 132
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs56585417
- Full Text :
- https://doi.org/10.1182/blood-2018-99-117600